AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2021
Nov 4, 2021
32915_dirs_2021-11-03_86819c16-0a7c-4ce3-aa79-b1ead3d4bb62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-11-01
Reporting Person: Kompella Uday (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-01 | Common Stock | S | 25000 | $14.05 | Disposed | 179416 | Indirect |
| 2021-11-02 | Common Stock | S | 25000 | $16.01 | Disposed | 154416 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 550674 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
More from Ocugen, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4